FindTrial
Sign In

Long-term study of imidafenacin in patients with overactive bladder

Long-term study of imidafenacin in patients with overactive bladder

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220423
Enrollment
Unknown
Registered
2007-08-06
Start date
2007-08-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

investigational material(s) Generic name etc : Imidafenacin|KRP-197/ONO-8025 INN of investigational material : Therapeutic category code : 251 Agents affecting urinary organs Dosage and Administratio

Sponsors

Kyorin Pharmaceutical Co.,Ltd. Ono Pharmaceutical Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Key Inclusion Criteria 1. Men and women >= 20 years old 2. Patients with urgency, urinary frequency and urgency incontinence Key Exclusion Criteria 1. Patients with genuine stress incontinence 2. Patients suffering from complications such as bladder tumor, urinary tract stone and symptomatic urinary tract infection 3. Patients suffering from complications contraindicating the use of antimuscarinic medication 4. Patients with polyuria

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Safety, efficacy—

Contacts

Public Contact; ;

Kyorin Pharmaceutical Co., Ltd.;Ono Pharmaceutical Co., Ltd.

;;

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026